Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03596268 · ClinicalTrials.gov registry record

Functional Imaging Reserve in NeuroHIV

A clinical trial of HIV, sponsored by Washington University School of Medicine.

Completed
Registry status
284
Enrollment target
1
Study location

NCT03596268 is a study of HIV that has completed, run by Washington University School of Medicine. The registered enrollment target is 284 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03596268, a study of HIV, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
284 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to look at the brain's efficiency and ability to make up for deficits in the front of the brain to see if people living with HIV (PLWH) are still able to perform well on various cognitive tasks even though there are other underlying processes at work, like inflammation, that affect the brain in a negative way. Results of this study may provide insight into the pathophysiology of disease and may reveal arenas for future possible interventions in PLWH who have impaired neuropsychological performance.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Imaging
  • DIAGNOSTIC_TEST Serum Laboratory Tests
  • DIAGNOSTIC_TEST Lumbar Puncture

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 284 participants
Start Date 2018-11-20
Est. Completion 2025-04-30

What the Registry Record Tells You About NCT03596268

The ClinicalTrials.gov registry entry for NCT03596268 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 284 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (35% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 3 interventions - of which Imaging is the first listed.

NCT03596268 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT03596268 about?

NCT03596268 is a clinical study titled "Functional Imaging Reserve in NeuroHIV". The purpose of this research study is to look at the brain's efficiency and ability to make up for deficits in the front of the brain to see if people living with HIV (PLWH) are still able to perform well on various cognitive tasks even though there are other underlying processes at work, like infla...

What is the current status of trial NCT03596268?

This trial is currently completed. The enrollment target is 284 participants. The study started on 2018-11-20. Estimated completion is 2025-04-30.

What conditions does trial NCT03596268 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT03596268?

The interventions under investigation include: Imaging (DIAGNOSTIC_TEST), Serum Laboratory Tests (DIAGNOSTIC_TEST), Lumbar Puncture (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03596268?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03596268 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.